An entire retail park in Cornwall that went to auction received nearly 100 separate bids. The trading estate with ...

Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC: Basel Tuesday, July 29, 2025, 10:00 Hrs [IST] Roche ann ...

From Dana to David Norris to Brian Lenihan's "mature recollections" and Sean Gallagher's last-minute TV ambush, we look back ...

The MTA’s plan to modernize signals on the G train will take longer than planned, transit officials said Monday, with an ...

TORONTO -- An investigational antibody drug, designed to cross the blood-brain barrier (BBB) to eliminate amyloid-beta ...

In a Phase Ib/IIa trial, 91% of patients receiving the highest dose of trontinemab were amyloid negative after seven months of treatment, representing what B. Riley Securities called a “paradigm shift ...

Discover how Obexelimab's unique B-cell inhibition and pivotal Phase 3 IgG4 results could drive Zenas BioPharma, Inc.'s ...

(Reuters) -The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, ...

Roche is in discussions with HHS to launch a direct-to-patient drug distribution model. CEO Thomas Schinecker said the move is being considered as a way to reduce prices for patients, pointing to the ...

Trontinemab is a formulation of Roche's failed gantenerumab but now paired with the company's Brainshuttle technology to ...

In its own communique issued shortly after the FDA’s, Sarepta elaborated on the situation and confirmed a Roche statement to ...

Dan Roche and Mike Reiss highlight which Patriots players have stood out through four training camp practices.